img

Global Imatinib Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Imatinib Drug Market Insights, Forecast to 2034

Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.
Global Imatinib Drug market is expected to reach to US$ 2899 million in 2024, with a positive growth of %, compared with US$ 2781 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Imatinib Drug industry is evaluated to reach US$ 3621.8 million in 2029. The CAGR will be 3.8% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Imatinib Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Imatinib Drug market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Cipla Inc.
Apotex Inc.
Mylan Pharms Inc.
Segment by Type
Tablets
Capsules

Segment by Application


Chronic Myelogenous Leukemia
Gastrointestinal Stromal Tumors
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Imatinib Drug plant distribution, commercial date of Imatinib Drug, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Imatinib Drug introduction, etc. Imatinib Drug Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Imatinib Drug
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Imatinib Drug Product Introduction
1.2 Market by Type
1.2.1 Global Imatinib Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Tablets
1.2.3 Capsules
1.3 Market by Application
1.3.1 Global Imatinib Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Chronic Myelogenous Leukemia
1.3.3 Gastrointestinal Stromal Tumors
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Imatinib Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Imatinib Drug Revenue by Region
2.2.1 Global Imatinib Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Imatinib Drug Revenue by Region (2018-2024)
2.2.3 Global Imatinib Drug Revenue by Region (2024-2029)
2.2.4 Global Imatinib Drug Revenue Market Share by Region (2018-2029)
2.3 Global Imatinib Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Imatinib Drug Sales by Region
2.4.1 Global Imatinib Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Imatinib Drug Sales by Region (2018-2024)
2.4.3 Global Imatinib Drug Sales by Region (2024-2029)
2.4.4 Global Imatinib Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Imatinib Drug Sales by Manufacturers
3.1.1 Global Imatinib Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Imatinib Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Imatinib Drug in 2022
3.2 Global Imatinib Drug Revenue by Manufacturers
3.2.1 Global Imatinib Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Imatinib Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Imatinib Drug Revenue in 2022
3.3 Global Key Players of Imatinib Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Imatinib Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Imatinib Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Imatinib Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Imatinib Drug, Product Offered and Application
3.8 Global Key Manufacturers of Imatinib Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Imatinib Drug Sales by Type
4.1.1 Global Imatinib Drug Historical Sales by Type (2018-2024)
4.1.2 Global Imatinib Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Imatinib Drug Sales Market Share by Type (2018-2029)
4.2 Global Imatinib Drug Revenue by Type
4.2.1 Global Imatinib Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Imatinib Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Imatinib Drug Revenue Market Share by Type (2018-2029)
4.3 Global Imatinib Drug Price by Type
4.3.1 Global Imatinib Drug Price by Type (2018-2024)
4.3.2 Global Imatinib Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Imatinib Drug Sales by Application
5.1.1 Global Imatinib Drug Historical Sales by Application (2018-2024)
5.1.2 Global Imatinib Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Imatinib Drug Sales Market Share by Application (2018-2029)
5.2 Global Imatinib Drug Revenue by Application
5.2.1 Global Imatinib Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Imatinib Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Imatinib Drug Revenue Market Share by Application (2018-2029)
5.3 Global Imatinib Drug Price by Application
5.3.1 Global Imatinib Drug Price by Application (2018-2024)
5.3.2 Global Imatinib Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Imatinib Drug Market Size by Type
6.1.1 US & Canada Imatinib Drug Sales by Type (2018-2029)
6.1.2 US & Canada Imatinib Drug Revenue by Type (2018-2029)
6.2 US & Canada Imatinib Drug Market Size by Application
6.2.1 US & Canada Imatinib Drug Sales by Application (2018-2029)
6.2.2 US & Canada Imatinib Drug Revenue by Application (2018-2029)
6.3 US & Canada Imatinib Drug Market Size by Country
6.3.1 US & Canada Imatinib Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Imatinib Drug Sales by Country (2018-2029)
6.3.3 US & Canada Imatinib Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Imatinib Drug Market Size by Type
7.1.1 Europe Imatinib Drug Sales by Type (2018-2029)
7.1.2 Europe Imatinib Drug Revenue by Type (2018-2029)
7.2 Europe Imatinib Drug Market Size by Application
7.2.1 Europe Imatinib Drug Sales by Application (2018-2029)
7.2.2 Europe Imatinib Drug Revenue by Application (2018-2029)
7.3 Europe Imatinib Drug Market Size by Country
7.3.1 Europe Imatinib Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Imatinib Drug Sales by Country (2018-2029)
7.3.3 Europe Imatinib Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Imatinib Drug Market Size
8.1.1 China Imatinib Drug Sales (2018-2029)
8.1.2 China Imatinib Drug Revenue (2018-2029)
8.2 China Imatinib Drug Market Size by Application
8.2.1 China Imatinib Drug Sales by Application (2018-2029)
8.2.2 China Imatinib Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Imatinib Drug Market Size by Type
9.1.1 Asia Imatinib Drug Sales by Type (2018-2029)
9.1.2 Asia Imatinib Drug Revenue by Type (2018-2029)
9.2 Asia Imatinib Drug Market Size by Application
9.2.1 Asia Imatinib Drug Sales by Application (2018-2029)
9.2.2 Asia Imatinib Drug Revenue by Application (2018-2029)
9.3 Asia Imatinib Drug Sales by Region
9.3.1 Asia Imatinib Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Imatinib Drug Revenue by Region (2018-2029)
9.3.3 Asia Imatinib Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Imatinib Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Imatinib Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Imatinib Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Imatinib Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Imatinib Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Imatinib Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Imatinib Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Imatinib Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Imatinib Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Imatinib Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Imatinib Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Novartis Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Glenmark Pharmaceuticals Ltd.
11.2.1 Glenmark Pharmaceuticals Ltd. Company Information
11.2.2 Glenmark Pharmaceuticals Ltd. Overview
11.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Glenmark Pharmaceuticals Ltd. Recent Developments
11.3 Sun Pharmaceuticals
11.3.1 Sun Pharmaceuticals Company Information
11.3.2 Sun Pharmaceuticals Overview
11.3.3 Sun Pharmaceuticals Imatinib Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Sun Pharmaceuticals Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sun Pharmaceuticals Recent Developments
11.4 Actavis Generics
11.4.1 Actavis Generics Company Information
11.4.2 Actavis Generics Overview
11.4.3 Actavis Generics Imatinib Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Actavis Generics Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Actavis Generics Recent Developments
11.5 Dr. Reddy's Laboratories
11.5.1 Dr. Reddy's Laboratories Company Information
11.5.2 Dr. Reddy's Laboratories Overview
11.5.3 Dr. Reddy's Laboratories Imatinib Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Dr. Reddy's Laboratories Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Dr. Reddy's Laboratories Recent Developments
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Teva Pharmaceutical Industries Ltd. Company Information
11.6.2 Teva Pharmaceutical Industries Ltd. Overview
11.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.7 Sanofi S.A.
11.7.1 Sanofi S.A. Company Information
11.7.2 Sanofi S.A. Overview
11.7.3 Sanofi S.A. Imatinib Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Sanofi S.A. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi S.A. Recent Developments
11.8 Cipla Inc.
11.8.1 Cipla Inc. Company Information
11.8.2 Cipla Inc. Overview
11.8.3 Cipla Inc. Imatinib Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Cipla Inc. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Cipla Inc. Recent Developments
11.9 Apotex Inc.
11.9.1 Apotex Inc. Company Information
11.9.2 Apotex Inc. Overview
11.9.3 Apotex Inc. Imatinib Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Apotex Inc. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Apotex Inc. Recent Developments
11.10 Mylan Pharms Inc.
11.10.1 Mylan Pharms Inc. Company Information
11.10.2 Mylan Pharms Inc. Overview
11.10.3 Mylan Pharms Inc. Imatinib Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Mylan Pharms Inc. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mylan Pharms Inc. Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Imatinib Drug Industry Chain Analysis
12.2 Imatinib Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Imatinib Drug Production Mode & Process
12.4 Imatinib Drug Sales and Marketing
12.4.1 Imatinib Drug Sales Channels
12.4.2 Imatinib Drug Distributors
12.5 Imatinib Drug Customers
13 Market Dynamics
13.1 Imatinib Drug Industry Trends
13.2 Imatinib Drug Market Drivers
13.3 Imatinib Drug Market Challenges
13.4 Imatinib Drug Market Restraints
14 Key Findings in The Global Imatinib Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Imatinib Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Capsules
Table 4. Global Imatinib Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Imatinib Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Imatinib Drug Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Imatinib Drug Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Imatinib Drug Revenue Market Share by Region (2018-2024)
Table 9. Global Imatinib Drug Revenue Market Share by Region (2024-2029)
Table 10. Global Imatinib Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Imatinib Drug Sales by Region (2018-2024) & (K Units)
Table 12. Global Imatinib Drug Sales by Region (2024-2029) & (K Units)
Table 13. Global Imatinib Drug Sales Market Share by Region (2018-2024)
Table 14. Global Imatinib Drug Sales Market Share by Region (2024-2029)
Table 15. Global Imatinib Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Imatinib Drug Sales Share by Manufacturers (2018-2024)
Table 17. Global Imatinib Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Imatinib Drug Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Imatinib Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Imatinib Drug Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Imatinib Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Imatinib Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Drug as of 2022)
Table 23. Global Key Manufacturers of Imatinib Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Imatinib Drug, Product Offered and Application
Table 25. Global Key Manufacturers of Imatinib Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Imatinib Drug Sales by Type (2018-2024) & (K Units)
Table 28. Global Imatinib Drug Sales by Type (2024-2029) & (K Units)
Table 29. Global Imatinib Drug Sales Share by Type (2018-2024)
Table 30. Global Imatinib Drug Sales Share by Type (2024-2029)
Table 31. Global Imatinib Drug Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Imatinib Drug Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Imatinib Drug Revenue Share by Type (2018-2024)
Table 34. Global Imatinib Drug Revenue Share by Type (2024-2029)
Table 35. Imatinib Drug Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Imatinib Drug Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Imatinib Drug Sales by Application (2018-2024) & (K Units)
Table 38. Global Imatinib Drug Sales by Application (2024-2029) & (K Units)
Table 39. Global Imatinib Drug Sales Share by Application (2018-2024)
Table 40. Global Imatinib Drug Sales Share by Application (2024-2029)
Table 41. Global Imatinib Drug Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Imatinib Drug Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Imatinib Drug Revenue Share by Application (2018-2024)
Table 44. Global Imatinib Drug Revenue Share by Application (2024-2029)
Table 45. Imatinib Drug Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Imatinib Drug Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Imatinib Drug Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Imatinib Drug Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Imatinib Drug Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Imatinib Drug Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Imatinib Drug Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Imatinib Drug Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Imatinib Drug Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Imatinib Drug Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Imatinib Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Imatinib Drug Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Imatinib Drug Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Imatinib Drug Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Imatinib Drug Sales by Country (2024-2029) & (K Units)
Table 60. Europe Imatinib Drug Sales by Type (2018-2024) & (K Units)
Table 61. Europe Imatinib Drug Sales by Type (2024-2029) & (K Units)
Table 62. Europe Imatinib Drug Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Imatinib Drug Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Imatinib Drug Sales by Application (2018-2024) & (K Units)
Table 65. Europe Imatinib Drug Sales by Application (2024-2029) & (K Units)
Table 66. Europe Imatinib Drug Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Imatinib Drug Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Imatinib Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Imatinib Drug Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Imatinib Drug Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Imatinib Drug Sales by Country (2018-2024) & (K Units)
Table 72. Europe Imatinib Drug Sales by Country (2024-2029) & (K Units)
Table 73. China Imatinib Drug Sales by Type (2018-2024) & (K Units)
Table 74. China Imatinib Drug Sales by Type (2024-2029) & (K Units)
Table 75. China Imatinib Drug Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Imatinib Drug Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Imatinib Drug Sales by Application (2018-2024) & (K Units)
Table 78. China Imatinib Drug Sales by Application (2024-2029) & (K Units)
Table 79. China Imatinib Drug Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Imatinib Drug Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Imatinib Drug Sales by Type (2018-2024) & (K Units)
Table 82. Asia Imatinib Drug Sales by Type (2024-2029) & (K Units)
Table 83. Asia Imatinib Drug Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Imatinib Drug Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Imatinib Drug Sales by Application (2018-2024) & (K Units)
Table 86. Asia Imatinib Drug Sales by Application (2024-2029) & (K Units)
Table 87. Asia Imatinib Drug Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Imatinib Drug Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Imatinib Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Imatinib Drug Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Imatinib Drug Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Imatinib Drug Sales by Region (2018-2024) & (K Units)
Table 93. Asia Imatinib Drug Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Imatinib Drug Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Imatinib Drug Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Imatinib Drug Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Imatinib Drug Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Imatinib Drug Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Imatinib Drug Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Imatinib Drug Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Imatinib Drug Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Imatinib Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Imatinib Drug Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Imatinib Drug Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Imatinib Drug Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Imatinib Drug Sales by Country (2024-2029) & (K Units)
Table 107. Novartis Company Information
Table 108. Novartis Description and Major Businesses
Table 109. Novartis Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Novartis Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Novartis Recent Developments
Table 112. Glenmark Pharmaceuticals Ltd. Company Information
Table 113. Glenmark Pharmaceuticals Ltd. Description and Major Businesses
Table 114. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Glenmark Pharmaceuticals Ltd. Recent Developments
Table 117. Sun Pharmaceuticals Company Information
Table 118. Sun Pharmaceuticals Description and Major Businesses
Table 119. Sun Pharmaceuticals Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Sun Pharmaceuticals Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sun Pharmaceuticals Recent Developments
Table 122. Actavis Generics Company Information
Table 123. Actavis Generics Description and Major Businesses
Table 124. Actavis Generics Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Actavis Generics Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Actavis Generics Recent Developments
Table 127. Dr. Reddy's Laboratories Company Information
Table 128. Dr. Reddy's Laboratories Description and Major Businesses
Table 129. Dr. Reddy's Laboratories Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Dr. Reddy's Laboratories Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Dr. Reddy's Laboratories Recent Developments
Table 132. Teva Pharmaceutical Industries Ltd. Company Information
Table 133. Teva Pharmaceutical Industries Ltd. Description and Major Businesses
Table 134. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 137. Sanofi S.A. Company Information
Table 138. Sanofi S.A. Description and Major Businesses
Table 139. Sanofi S.A. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Sanofi S.A. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Sanofi S.A. Recent Developments
Table 142. Cipla Inc. Company Information
Table 143. Cipla Inc. Description and Major Businesses
Table 144. Cipla Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. Cipla Inc. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Cipla Inc. Recent Developments
Table 147. Apotex Inc. Company Information
Table 148. Apotex Inc. Description and Major Businesses
Table 149. Apotex Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Apotex Inc. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Apotex Inc. Recent Developments
Table 152. Mylan Pharms Inc. Company Information
Table 153. Mylan Pharms Inc. Description and Major Businesses
Table 154. Mylan Pharms Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Mylan Pharms Inc. Imatinib Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Mylan Pharms Inc. Recent Developments
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Imatinib Drug Distributors List
Table 160. Imatinib Drug Customers List
Table 161. Imatinib Drug Market Trends
Table 162. Imatinib Drug Market Drivers
Table 163. Imatinib Drug Market Challenges
Table 164. Imatinib Drug Market Restraints
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Imatinib Drug Product Picture
Figure 2. Global Imatinib Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Imatinib Drug Market Share by Type in 2022 & 2029
Figure 4. Tablets Product Picture
Figure 5. Capsules Product Picture
Figure 6. Global Imatinib Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Imatinib Drug Market Share by Application in 2022 & 2029
Figure 8. Chronic Myelogenous Leukemia
Figure 9. Gastrointestinal Stromal Tumors
Figure 10. Others
Figure 11. Imatinib Drug Report Years Considered
Figure 12. Global Imatinib Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Imatinib Drug Revenue 2018-2029 (US$ Million)
Figure 14. Global Imatinib Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Imatinib Drug Revenue Market Share by Region (2018-2029)
Figure 16. Global Imatinib Drug Sales 2018-2029 ((K Units)
Figure 17. Global Imatinib Drug Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Imatinib Drug Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Imatinib Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Imatinib Drug Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Imatinib Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Imatinib Drug Sales YoY (2018-2029) & (K Units)
Figure 23. China Imatinib Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Imatinib Drug Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Imatinib Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Imatinib Drug Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Imatinib Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Imatinib Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Imatinib Drug in the World: Market Share by Imatinib Drug Revenue in 2022
Figure 30. Global Imatinib Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Imatinib Drug Sales Market Share by Type (2018-2029)
Figure 32. Global Imatinib Drug Revenue Market Share by Type (2018-2029)
Figure 33. Global Imatinib Drug Sales Market Share by Application (2018-2029)
Figure 34. Global Imatinib Drug Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Imatinib Drug Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Imatinib Drug Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Imatinib Drug Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Imatinib Drug Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Imatinib Drug Revenue Share by Country (2018-2029)
Figure 40. US & Canada Imatinib Drug Sales Share by Country (2018-2029)
Figure 41. U.S. Imatinib Drug Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Imatinib Drug Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Imatinib Drug Sales Market Share by Type (2018-2029)
Figure 44. Europe Imatinib Drug Revenue Market Share by Type (2018-2029)
Figure 45. Europe Imatinib Drug Sales Market Share by Application (2018-2029)
Figure 46. Europe Imatinib Drug Revenue Market Share by Application (2018-2029)
Figure 47. Europe Imatinib Drug Revenue Share by Country (2018-2029)
Figure 48. Europe Imatinib Drug Sales Share by Country (2018-2029)
Figure 49. Germany Imatinib Drug Revenue (2018-2029) & (US$ Million)
Figure 50. France Imatinib Drug Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Imatinib Drug Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Imatinib Drug Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Imatinib Drug Revenue (2018-2029) & (US$ Million)
Figure 54. China Imatinib Drug Sales Market Share by Type (2018-2029)
Figure 55. China Imatinib Drug Revenue Market Share by Type (2018-2029)
Figure 56. China Imatinib Drug Sales Market Share by Application (2018-2029)
Figure 57. China Imatinib Drug Revenue Market Share by Application (2018-2029)
Figure 58. Asia Imatinib Drug Sales Market Share by Type (2018-2029)
Figure 59. Asia Imatinib Drug Revenue Market Share by Type (2018-2029)
Figure 60. Asia Imatinib Drug Sales Market Share by Application (2018-2029)
Figure 61. Asia Imatinib Drug Revenue Market Share by Application (2018-2029)
Figure 62. Asia Imatinib Drug Revenue Share by Region (2018-2029)
Figure 63. Asia Imatinib Drug Sales Share by Region (2018-2029)
Figure 64. Japan Imatinib Drug Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Imatinib Drug Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Imatinib Drug Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Imatinib Drug Revenue (2018-2029) & (US$ Million)
Figure 68. India Imatinib Drug Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Imatinib Drug Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Imatinib Drug Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Imatinib Drug Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Imatinib Drug Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Imatinib Drug Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Imatinib Drug Sales Share by Country (2018-2029)
Figure 75. Brazil Imatinib Drug Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Imatinib Drug Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Imatinib Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Imatinib Drug Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Imatinib Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Imatinib Drug Value Chain
Figure 81. Imatinib Drug Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries